TIGIT and COVID-19: For example, Demaria et al. observed higher levels of NKG2A, PD-1, and CD39 in COVID-19-associated NK cells from the peripheral blood and bronchoalveolar lavage fluid (15), while Krämer et al. detected increased TIGIT expression on NK cells in some COVID-19 patients (14).